Learn More
Invitrogen™ PACT Polyclonal Antibody

Description
Recommended positive controls: A549, HeLa, Jurkat, NT2D. Predicted reactivity: Mouse (98%), Rat (98%), Rhesus Monkey (100%), Chimpanzee (99%), Bovine (97%). Store product as a concentrated solution. Centrifuge briefly prior to opening the vial.
Specifications
Specifications
| Antigen | PACT |
| Applications | Western Blot |
| Classification | Polyclonal |
| Concentration | 0.51 mg/mL |
| Conjugate | Unconjugated |
| Formulation | 0.1M tris glycine with 20% glycerol and 0.01% thimerosal; pH 7 |
| Gene | PRKRA |
| Gene Accession No. | O75569 |
| Gene Alias | AV120107; DYT16; HSD14; HSD-14; interferon-inducible double stranded RNA-dependent protein kinase activator A; interferon-inducible double-stranded RNA-dependent protein kinase activator A; lear; PACT; PKR associated protein X; PKR-associated protein X; PKR-associating protein X; PRK; PRKRA; protein activator of interferon induced protein kinase EIF2AK2; protein activator of the interferon-induced protein kinase; protein kinase, interferon inducible double stranded RNA dependent activator; protein kinase, interferon-inducible double stranded RNA dependent activator; protein kinase, interferon-inducible double stranded RNA-dependent activator; protein kinase, interferon-inducible double-stranded RNA-dependent activator; RAX |
| Gene Symbols | PRKRA |
| Show More |
Safety and Handling
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.